IL7 and neoplasm: For example, IL-7-producing immunotherapy improves the ex vivo T cell functions of immunosenescent patients [113], and IL-7 can sustain the CD27/CD28 expression and proliferative capacity to restrain tumor-induced T cell senescence [114].